Journal of Integrative Oncology

Fernanda Maris Peria

Publications

• Research Article
  Cost Evaluation of Metastatic Colorectal Cancer Treatment in the Brazilian Public Healthcare System
  Author(s): Andrea Queiróz Ungari, Leonardo Régis Leira Pereira, Gleici da Silva Castro Perdoná, Bárbara Beltrame Bettim, Altacílio Aparecido Nunes, Liane Rapatoni, Harley Francisco de Oliveira and Fernanda Maris PeriaAndrea Queiróz Ungari, Leonardo Régis Leira Pereira, Gleici da Silva Castro Perdoná, Bárbara Beltrame Bettim, Altacílio Aparecido Nunes, Liane Rapatoni, Harley Francisco de Oliveira and Fernanda Maris Peria
  
  Objective: The study aimed at evaluating and comparing healthcare-related costs for metastatic colorectal cancer treatment among patients receiving systemic (chemotherapy or biotherapy) therapy, considering both costs per treatment cycle and total costs per patient.Methods: This was a cross-sectional, econometric study conducted in a public, tertiary referral hospital in Brazil, which is supported by national and state level funding. Data were collected between January 01, 2009 and October 31, 2013. Micro-costing method was employed to estimate costs related to medication, laboratory tests, imaging tests, drug preparation and administration.Results: The XELOX plus bevacizumab therapy presented the highest average cost per cycle, 7,701 Brazilian reals, followed by FOLFIRI plus bevacizumab, with an average cost of 6,927 Braz.. Read More»
  DOI: 10.4172/2329-6771.1000136

  Abstract PDF